Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) — NCD 151 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 151, the national coverage determination governing TENS and NMES supply coverage, effective March 7, 2026. This update clarifies when form-fitting conductive garments are covered as an alternative to conventional electrodes — and your documentation needs to match the criteria exactly or you'll face claim denial.

The CMS TENS and NMES coverage policy under NCD 151 Medicare has been in place for years, but this modification brings renewed scrutiny to a benefit that many billing teams treat as routine. The policy does not list specific CPT or HCPCS codes in this version — which creates its own documentation burden, covered below. If your practice or DME operation bills for TENS or NMES supplies, read this before March 7, 2026.

Quick-Reference Table

CMS TENS and NMES Coverage Criteria and Medical Necessity Requirements 2026

NCD 151 is the national coverage determination governing Medicare coverage of supplies used to deliver transcutaneous electrical nerve stimulation and neuromuscular electrical stimulation. The core of this policy is straightforward: conventional electrodes, adhesive tapes, and lead wires are the standard. A form-fitting conductive garment is the exception — and Medicare only pays for the exception when you can prove the standard doesn't work for that patient.

The coverage policy requires three things to be true at once. First, the garment must have FDA marketing permission or approval. Second, a physician must prescribe it specifically for covered TENS or NMES treatment. Third — and this is where most documentation falls apart — one of five clinical indications must be met and documented.

The Five Medical Necessity Indications for Conductive Garments

CMS allows a form-fitting conductive garment only when the patient meets one of these conditions:

Every one of these indications requires documentation. "Patient preferred the garment" is not a covered indication. "Conventional electrodes were tried" without clinical notes explaining why they failed is not enough. The medical record must speak to the specific criterion — before the claim hits the Medicare Administrative Contractor's desk.

The Trial Period Restriction

There's an important carve-out that trips up billing teams on TENS cases. During the trial period for TENS coverage (as defined in NCD §160.3), a conductive garment is not covered — with two narrow exceptions.

The patient must have a documented skin problem before the trial period starts. And the B/MAC's medical consultants must be satisfied that the garment is medically necessary for that specific patient.

This isn't a formality. The MAC's medical consultants have active review authority here. If you're billing a conductive garment during a TENS trial period, your documentation needs to be airtight before you submit. If you're not sure whether your patient's trial period applies, talk to your compliance officer before the effective date of March 7, 2026.

CMS Conductive Garment Exclusions and Non-Covered Indications

The policy is clear on what doesn't qualify. A form-fitting conductive garment is not a substitute for conventional supplies simply because it's more convenient, better tolerated, or preferred by the patient.

Garments used with a TENS device during the trial period — without meeting the skin condition and MAC-approval criteria above — are not covered. Full stop. If those two conditions aren't both satisfied, the claim will face denial regardless of clinical rationale.

The policy also builds in a structural constraint: the garment must replace conventional electrodes because conventional electrodes genuinely cannot do the job for that patient. If conventional electrodes were never tried, or if the record doesn't explain why they're not feasible, you've got a documentation gap that makes reimbursement unlikely.

Coverage Indications at a Glance

CMS TENS and NMES Billing Guidelines and Action Items 2026

This policy change requires documentation discipline more than it requires billing changes. Here's what to do before March 7, 2026.

CPT, HCPCS, and ICD-10 Codes for TENS and NMES Supplies Under NCD 151

Covered CPT and HCPCS Codes

The policy data for NCD 151 does not list specific CPT or HCPCS codes. This is common for NCD-level supply policies, where code applicability depends on the specific garment billed and the B/MAC's local coverage determination.

Your Medicare Administrative Contractor may have issued an LCD that maps specific HCPCS codes — commonly in the A and E code ranges for DME and supplies — to this NCD. Check with your MAC directly, or query your MAC's LCD database for conductive garment and TENS/NMES supply codes applicable to your jurisdiction.

Key ICD-10-CM Diagnosis Codes

NCD 151 does not specify ICD-10-CM codes. Diagnosis coding for TENS and NMES claims should reflect the underlying condition driving the covered indication — chronic intractable pain, disuse atrophy, post-injury rehabilitation need, or the documented skin condition. Your MAC's LCD, if one exists, is the best source for covered diagnosis codes by indication.

Do not report diagnosis codes not supported by the medical record. The covered indication and the diagnosis code must align. Mismatches between the clinical notes and the reported diagnosis are a common audit trigger for TENS and NMES billing.